Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven W de Taeye

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
Cell|December 22, 2015
Immunogenicity of Stabilized HIV-1 Envelope Trimers with Reduced Exposure of Non-neutralizing EpitopesSteven W de Taeye, Gabriel Ozorowski, Alba Torrents de la Peña, et al.
The Journal of Experimental Medicine|August 30, 2017
Design and crystal structure of a native-like HIV-1 envelope trimer that engages multiple broadly neutralizing antibody precursors in vivoMax Medina-Ramírez, Fernando Garces, Amelia Escolano, et al.
Science (New York, N.Y.)|December 28, 2020
Afucosylated IgG characterizes enveloped viral responses and correlates with COVID-19 severityMads Delbo Larsen, Erik L de Graaf, Myrthe E Sonneveld, et al.
Nature Communications|August 4, 2022
A public antibody class recognizes an S2 epitope exposed on open conformations of SARS-CoV-2 spikeMathieu Claireaux, Tom G Caniels, Marlon de Gast, et al.
Cell Reports. Medicine|April 12, 2023
Germline-targeting HIV-1 Env vaccination induces VRC01-class antibodies with rare insertionsTom G Caniels, Max Medina-Ramírez, Jinsong Zhang, et al.
Immunity|June 22, 2017
Elicitation of Robust Tier 2 Neutralizing Antibody Responses in Nonhuman Primates by HIV Envelope Trimer Immunization Using Optimized ApproachesMatthias Pauthner, Colin Havenar-Daughton, Devin Sok, et al.
Science Translational Medicine|May 12, 2021
High titers and low fucosylation of early human anti-SARS-CoV-2 IgG promote inflammation by alveolar macrophagesWillianne Hoepel, Hung-Jen Chen, Chiara E Geyer, et al.
The Journal of Allergy and Clinical Immunology|January 30, 2023
Differences in IgG autoantibody Fab glycosylation across autoimmune diseasesJana Koers, Rocco Sciarrillo, Ninotska I L Derksen, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Cell|December 22, 2015
Immunogenicity of Stabilized HIV-1 Envelope Trimers with Reduced Exposure of Non-neutralizing EpitopesSteven W de Taeye, Gabriel Ozorowski, Alba Torrents de la Peña, et al.
The Journal of Experimental Medicine|August 30, 2017
Design and crystal structure of a native-like HIV-1 envelope trimer that engages multiple broadly neutralizing antibody precursors in vivoMax Medina-Ramírez, Fernando Garces, Amelia Escolano, et al.
Science (New York, N.Y.)|December 28, 2020
Afucosylated IgG characterizes enveloped viral responses and correlates with COVID-19 severityMads Delbo Larsen, Erik L de Graaf, Myrthe E Sonneveld, et al.
Nature Communications|August 4, 2022
A public antibody class recognizes an S2 epitope exposed on open conformations of SARS-CoV-2 spikeMathieu Claireaux, Tom G Caniels, Marlon de Gast, et al.
Cell Reports. Medicine|April 12, 2023
Germline-targeting HIV-1 Env vaccination induces VRC01-class antibodies with rare insertionsTom G Caniels, Max Medina-Ramírez, Jinsong Zhang, et al.
Immunity|June 22, 2017
Elicitation of Robust Tier 2 Neutralizing Antibody Responses in Nonhuman Primates by HIV Envelope Trimer Immunization Using Optimized ApproachesMatthias Pauthner, Colin Havenar-Daughton, Devin Sok, et al.
Science Translational Medicine|May 12, 2021
High titers and low fucosylation of early human anti-SARS-CoV-2 IgG promote inflammation by alveolar macrophagesWillianne Hoepel, Hung-Jen Chen, Chiara E Geyer, et al.
The Journal of Allergy and Clinical Immunology|January 30, 2023
Differences in IgG autoantibody Fab glycosylation across autoimmune diseasesJana Koers, Rocco Sciarrillo, Ninotska I L Derksen, et al.
Pageof 6